Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma
- 15 June 2000
- Vol. 88 (12) , 2677-2685
- https://doi.org/10.1002/1097-0142(20000615)88:12<2677::aid-cncr5>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyEuropean Journal Of Cancer, 1997
- Chemotherapy in non-small cell lung cancer: time to re-examine our attitudes.Thorax, 1996
- Local research ethics committeesBMJ, 1995
- Should non-small cell carcinoma of the lung be treated with chemotherapy? Con: therapeutic empiricism--the case against chemotherapy in non-small cell lung cancer.American Journal of Respiratory and Critical Care Medicine, 1995
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1994
- Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung CancerChest, 1994
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1991
- Chemotherapy and Survival of Patients with Non-Small Cell Lung CancerChest, 1991